ACRS: Aclaris Therapeutics, Inc. Net Assets per Single Share
The Aclaris Therapeutics (ACRS) price chart reflects the performance of a company whose immunological drug developments are currently in the testing phase, rendering commercial growth unattainable due to high R&D costs. The current value of the metric is 0.89, while operating income is absent and activities are sustained through external funding. The business focuses on developing dermatology therapies, targeting the skin treatment market.
Summary analytical data breakdowns for aclaristx.com (ACRS)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Aclaris Therapeutics|ACRS - Long-Term Debt to Capital|Short-Term Debt to Equity Aclaris Therapeutics, Inc.|ACRS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Aclaris Therapeutics, Inc.|ACRS - Company Long-Term Liabilities|Company Short-Term Debts Aclaris Therapeutics
General company analysis:ACRS - Aclaris
Book value per share reflects the portion of net assets attributable to a single security and serves as an indicator of the issuer's intrinsic value upon liquidation. By analyzing the book value per share ratio, an investor can assess the resource capitalization of Aclaris Therapeutics (ACRS), which, at the clinical trial stage in immunology, is limited by bioreagent costs and compliance with environmental disposal protocols.
Competitor analysis
ARGX - Net Assets per Single Share|Accounting Value of a Share BNTX (BioNTech Pharma)|Abivax Corp (ABVX) - Net Assets per Single Share|ADMA - Net Assets per Share|Net Assets per Single Share Protagonist|Immunovant Inc - Share Book Value|Book Value per Share KNSA|GRFS (Grifols Biemat) - Accounting Value of a Share|Book Value per Share ADPT (Adaptive Biotechnologies)|Book Value per Share celldex.com CLDX|AUPH - Net Assets per Single Share|Accounting Value of a Share BCRX (BioCryst Pharmaceuticals, Inc.)|Vera Pharma (VERA) - Net Assets per Single Share|Accounting Value per Share Dianthus Corp|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp|Accounting Value per Share TRML (Tourmaline Bio)|PGEN (Precigen Inc) - Accounting Value of a Share|Book Value per Share PHAR (Pharming)|Net Assets per Share Nektar Corp (NKTR)|UPB - Net Assets per Single Share|zenasbio.com (ZBIO) - Accounting Value per Share|Immunome (IMNM) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|Accounting Value per Share KALV|Book Value per Share Septerna Pharma|Net Assets per Single Share Pieris Pharmaceuticals (PVLA)|savarapharma.com - Equity per Share|Book Value per Share RIGL (Rigel Pharmaceuticals, Inc.)|AnaptysBio Inc (ANAB) - Net Asset Value per Share|Astria Pharma - Book Value per Share|ENGN - Book Value per Share|RAPT: Book Value per Share|Accounting Value per Share Aerovate Therapeutics|Net Assets per Single Share Kyverna Therapeutics, Inc.|Net Assets per Single Share TLSA|Book Value per Share CABA|Book Value per Share Ventyx Biosciences, Inc (VTYX)|Net Assets per Single Share Theratechnologies Inc. THTX|Accounting Value of a Share AVTX|Eledon Pharmaceuticals, Inc. - Book Value per Share|Net Assets per Share Agenus, Inc. AGEN|Climb Bio, Inc. (CLYM) - Net Assets per Single Share|ZURA - Net Assets per Share|Accounting Value per Share ATYR|ADAG: Accounting Value of a Share|Accounting Value per Share IMA (ImageneBio Inc)|Book Price of a Share STTK|Book Value per Share EQ (Equillium)|Accounting Value of a Share CNTB|Immunic Inc - Book Value per Share|Net Asset Value per Share Atara Biotherapeutics|inflarx.de (IFRX) - Net Assets per Single Share|X4 Pharmaceuticals Inc. - Accounting Value of a Share|ACET (Adicet Bio Inc.) - Book Value per Share|Book Value per Share Celularity Corp|Net Assets per Single Share INmune Bio, Inc. (INMB)|BRNS: Share Book Value|Book Value per Share KZR (Kezar Life Sciences, Inc.)|SAB Biotherapeutics Inc. (SABS) - Net Asset Value per Share|AKTX: Accounting Value per Share|ENLV - Book Value per Share|QTTB (q32bio.com) - Accounting Value per Share|GOVX: Book Price of a Share|EDSA (Edesa Biotech) - Book Value per Share|iBio Inc (IBIO) - Net Assets per Share|Book Value per Share CARM|Accounting Value per Share XTL Bio XTLB|Net Assets per Single Share Bolt Biotherapeutics, Inc. BOLT|Net Assets per Share HCW Biologics, Inc. (HCWB)|Aptevo - Book Value per Share|AIM - Book Value per Share|ADTX: Book Value per Share|Accounting Value per Share GRI Bio Corporation|Net Assets per Single Share XORTX Therapeutics Inc.|HIND: Accounting Value of a Share|Net Assets per Single Share Revelation Biosciences, Inc. (REVB)|Net Assets per Share Indaptus Therapeutics Inc|Net Assets per Single Share Scinai SCNI|CALI (CalciMedica Inc) - Share Book Value|Affimed Therapeutics - Book Value per Share|Accounting Value of a Share ALLK (Allakos Inc.)|HOOK: Book Value per Share|IGM Biosciences (IGMS) - Book Value per Share|Net Assets per Single Share iTeos|OCEA: Accounting Value of a Share|Net Assets per Single Share TC Biopharm (TCBP)|Accounting Value per Share thirdharmonicbio.com THRD